Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
autologous bone marrow (1 trial)
busulfan (myleran) (1 trial)
cytarabine (cytosar-u) (1 trial)
hydroxyurea (hydrea) (1 trial)
idarubicin (idamycin) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
peripheral blood hematopoietic cell (1 trial)
Leukemia (Phase 3)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 3)
Leukemia, Myeloid (Phase 3)
Trials (1 total)
Trial APIs (8 total)